Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al
Case Number:
3:18-cv-01994
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
August 26, 2021
Zydus To Appeal Takeda's Antitrust Win In Drug Patent Row
Zydus Pharmaceuticals Inc. moved Wednesday to appeal the dismissal of its antitrust counterclaims accusing Takeda Pharmaceutical Co. Ltd. of filing sham patent litigation to delay competition for heartburn medication Prevacid.
-
July 26, 2021
Takeda Beats Antitrust Claims In Heartburn Drug Patent Fight
A New Jersey federal judge on Monday tossed generic-drug maker Zydus Pharmaceuticals Inc.'s antitrust counterclaims accusing Takeda Pharmaceutical Co. Ltd. of filing sham patent litigation to delay competition for heartburn medication Prevacid, ruling there was no showing Takeda didn't have legitimate infringement concerns.
-
June 06, 2019
Takeda Bid To DQ Baker Botts 'Spurious At Best,' Judge Says
A New Jersey federal judge isn't buying Takeda Pharmaceutical Co.'s argument that it believes it is entitled to attorney-client privilege from Baker Botts after the law firm represented the drugmaker's co-plaintiff in a previous patent case.
-
January 14, 2019
Baker Botts Defeats Takeda's DQ Bid In Heartburn Drug Fight
Baker Botts LLP can continue representing Zydus Pharmaceuticals as it pursues antitrust claims against Takeda over a heartburn medication, despite the law firm's prior representation of Takeda's ally in patent litigation over the same drug, a New Jersey federal judge said in a ruling made public Friday.
-
December 20, 2018
Takeda's Patent Infringement Suit Not Antitrust-Proof
Patent infringement lawsuits challenging generic drug applications aren't automatically immune from antitrust claims, a New Jersey federal judge ruled Wednesday, refusing to toss counterclaims accusing Takeda Pharmaceutical Co. Ltd. of trying to illegally maintain its monopoly on a heartburn therapy with "sham" infringement claims.
-
June 05, 2018
Zydus Defends Antitrust Claims In Prevacid Patent Suit
Generic-drug maker Zydus on Monday urged a New Jersey federal judge to reject rival Takeda's bid to dodge antitrust counterclaims in a patent infringement suit over a generic for the dissolving heartburn relief tablet Prevacid SoluTab.